Literature DB >> 1852539

Detection and treatment of brucellosis by screening a population at risk.

O Abramson1, Z Rosenvasser, C Block, R Dagan.   

Abstract

Brucellosis presents a difficult diagnostic challenge in view of its protean manifestations, multiple organ involvement and variable clinical course. The purpose of the present study was to determine whether active screening of a population at risk, identified through index cases, would enhance the detection rate of brucellosis and improve treatment. During a 1-month period all 98 individuals sharing risk factors with 4 diagnosed symptomatic cases of brucellosis in one Bedouin town in southern Israel were approached and 86 agreed to undergo screening. Symptomatic brucellosis was found in 8 (9%) of the screened population and an additional 5 (6%) asymptomatic individuals were found to be seropositive. These 13 were followed for 12 months. All symptomatic cases were treated and cured. Of the 5 asymptomatic seropositive individuals 2 showed a further elevation of Brucella antibody titers. One became symptomatic, was treated and was cured. This screening program provided 53% of all reported cases from the Bedouin town during the entire year of the study. Screening a population at risk increased the detection rate of brucellosis and improved the treatment.

Entities:  

Mesh:

Year:  1991        PMID: 1852539     DOI: 10.1097/00006454-199106000-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Bartholin's gland abscess caused by Brucella melitensis.

Authors:  Neha Peled; Yohai David; Pablo Yagupsky
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 2.  Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases.

Authors:  S Gallien; S Fournier; R Porcher; J Bottero; P Ribaud; A Sulahian; G Socié; J-M Molina
Journal:  Infection       Date:  2008-11-13       Impact factor: 3.553

3.  Brucellosis screening and follow-up of seropositive asymptomatic subjects among household members of shepherds in China.

Authors:  Jing Hu; Xiangyi Zhang; Huixin Yang; Siwen Zhang; Taijun Wang; Shuqi An; Mujinyan Li; Fande Li; Jingjing Luo; Fangfang Hu; Dali Wang; Shaonan Ni; Jian Sheng; Cui Zhang; Qing Zhen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-07       Impact factor: 3.267

4.  Seroprevalence of brucella antibodies among persons in high-risk occupation in Lebanon.

Authors:  G F Araj; R A Azzam
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

5.  Comparison of BACTEC 9240 Peds Plus medium and isolator 1.5 microbial tube for detection of Brucella melitensis from blood cultures.

Authors:  P Yagupsky; N Peled; J Press; O Abramson; M Abu-Rashid
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

6.  Childhood brucellosis in north-western Greece: a retrospective analysis.

Authors:  E Galanakis; K L Bourantas; S Leveidiotou; P D Lapatsanis
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

7.  Rapid detection of Brucella melitensis from blood cultures by a commercial system.

Authors:  P Yagupsky; N Peled; J Press; M Abu-Rashid; O Abramson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 5.103

8.  Detection of Brucella melitensis by BACTEC NR660 blood culture system.

Authors:  P Yagupsky
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

Review 9.  Concentrated swine feeding operations and public health: a review of occupational and community health effects.

Authors:  D Cole; L Todd; S Wing
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

10.  Screening of family members of patients with acute brucellosis in an endemic area of Iran.

Authors:  Masoomeh Sofian; Leila Safaeipour; Arezoo Aghakhani; Mohammad Reza Sharif; Mohammad Banifazl; Alireza Sharif; Ali-Asghar Farazi; Ali Eslamifar; Farshideh Didgar; Amitis Ramezani
Journal:  Iran J Microbiol       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.